At a glance
- Originator Schering-Plough
- Class Anti-inflammatories; Antipsoriatics; Naphthyridines
- Mechanism of Action Leukotriene inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Skin disorders